Peptide
    Research Compound

    AOD-9604

    The Fat-Burning GH Fragment

    A modified fragment of growth hormone (176-191) that promotes fat loss without the negative effects of full GH, including no impact on blood sugar.

    Fat lossLipolysis enhancementNo blood sugar impactCartilage repair support

    About AOD-9604

    AOD-9604 is a modified fragment of human growth hormone consisting of amino acids 176-191 with an added tyrosine at the N-terminus. It was developed to provide the fat-burning benefits of growth hormone without its negative effects on blood sugar or cell proliferation. AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) without affecting IGF-1 levels or causing the issues associated with full GH therapy. It's also being studied for cartilage repair and osteoarthritis treatment.

    Mechanism of Action

    AOD-9604 mimics the lipolytic region of growth hormone, activating beta-3 adrenergic receptors in adipose tissue to stimulate fat breakdown. Unlike full GH, it doesn't bind to GH receptors responsible for cell proliferation or glucose regulation. This makes it a targeted fat-loss agent without the metabolic side effects. AOD-9604 also appears to stimulate cartilage repair by promoting chondrocyte activity.

    How AOD-9604 Works in Your Body:

    • Target Receptors: AOD-9604 binds to specific receptors that trigger downstream signaling cascades related to its primary benefits.
    • Physiological Response: The body responds by modulating natural processes—whether hormone release, tissue repair, or cellular signaling—without replacing endogenous function.
    • Timeline: Effects typically begin within 1-2 weeks, with optimal results seen over the recommended protocol duration.

    Dosing Protocol

    Frequency

    Once daily

    Timing

    Morning on empty stomach, or before fasted cardio

    Duration

    8-12 week cycles

    Important Notes

    250-300mcg subcutaneously. Some protocols use up to 500mcg. Best taken fasted and 30+ minutes before eating. Can be combined with other GH secretagogues.

    Clinical Research

    3 studies on AOD-9604

    Study #01

    Fat Loss Study

    AOD-9604 reduced body fat in obese subjects without affecting IGF-1, glucose, or insulin levels.

    Regulatory Peptides

    Study #02

    Lipogenesis Inhibition

    AOD-9604 inhibited both lipogenic and lipid-synthesizing enzymes in adipose tissue.

    Journal of Endocrinology

    Study #03

    Cartilage Repair

    AOD-9604 stimulated proteoglycan and collagen synthesis in human cartilage explants.

    Osteoarthritis and Cartilage

    Clinical Deep Dive

    AOD-9604 in Practice

    Evidence: Tier 2 (Single RCTs)Last reviewed: 2026-04-22

    Who AOD-9604 is for

    Adults pursuing body recomposition who want targeted adipose mobilization without the GH-related side effects (insulin resistance, water retention, joint discomfort). Often used in cosmetic and metabolic clinics as an adjunct to caloric deficit and resistance training.

    Who should avoid it

    Pregnant or nursing women, those with active malignancy, and anyone expecting it to replace caloric deficit — AOD-9604 is a metabolic adjunct, not a standalone fat-loss drug.

    Clinical Context

    AOD-9604 is a synthetic 16-amino-acid fragment of the C-terminus of human growth hormone (residues 177-191) with an added tyrosine. It was developed in the 1990s by Metabolic Pharmaceuticals as an oral anti-obesity drug. It mimics the lipolytic and anti-lipogenic actions of GH without the diabetogenic, growth, or IGF-1 effects. Phase IIb trials in 534 obese patients showed dose-dependent fat loss vs placebo, but the program was discontinued before Phase III due to commercial considerations rather than safety. AOD-9604 has GRAS (Generally Recognized As Safe) status in some jurisdictions but is not FDA-approved as a drug.

    Common Mistakes to Avoid

    Using it without caloric deficit

    AOD-9604 enhances lipolysis but cannot create energy imbalance on its own. Without a 300-500 kcal/day deficit, results will be invisible.

    Expecting GH-like effects

    AOD-9604 lacks the muscle-building and recovery properties of full GH or GH-stimulating peptides. If you want both fat loss and lean mass support, pair it with ipamorelin/CJC-1295.

    Stopping at 4 weeks

    Visible recomposition takes 12-16 weeks of consistent dosing combined with training and diet.

    Potential Side Effects

    • Generally very well tolerated
    • Injection site reactions
    • Rare: headache, nausea

    Stacks Well With

    Combining peptides can create synergistic effects. Learn about optimal timing, dosing, and protocols.

    Learn More About AOD-9604

    Explore our research library and educational resources to understand how AOD-9604 can support your health goals.